ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,310.80
0.41%
Dow Jones
38,239.66
0.40%
Brent Oil
87.83
0.17%
Bitcoin
62,320.86
-1.08%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Manolete Partners Plc (MANO) Quote

Manolete Partners Plc

Manolete Partners Plc (MANO)

LSE
142.50
0.00
( 0.00% )
Updated: 03:00:00
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
142.50
Bid
140.00
Ask
145.00
Volume
2,700
142.50 Day's Range 142.50
109.50 52 Week Range 250.00
Market Cap
62.36M
Previous Close
142.50
Open
142.50
Last Trade
2700
@
143
(UT)
Last Trade Time
04:00:20
Financial Volume
3,861p
VWAP
143.00
Average Volume (3m)
19,233
Shares Outstanding
43,761,305
Dividend Yield
-
PE Ratio
-19.96
Earnings Per Share (EPS)
-0.07
Revenue
20.75M
Net Profit
-3.12M

About Manolete Partners Plc

Sector
Legal Services
Industry
Legal Services
Website
www.manolete-partners.com
Headquarters
Buckinghamshire, Gbr
Founded
1970
Manolete Partners Plc is listed in the Legal Services sector of the London Stock Exchange with ticker MANO. The last closing price for Manolete Partners was 142.50p. Over the last year, Manolete Partners shares have traded in a share price range of 109.50p to 250.00p.

Manolete Partners currently has 43,761,305 shares outstanding. The market capitalization of Manolete Partners is £62.36 million. Manolete Partners has a price to earnings ratio (PE ratio) of -19.96.

MANO Latest News

More News

Manolete Partners celebrates return to profit in financial 2024

Manolete Partners PLC on Thursday said in the year ended March, it saw strong momentum and a return to profit. The B ...

April 19 2024
Alliance News

Manolete Partners PLC Trading and Business Update

Manolete Partners PLC 18 April 2024   18 April 2024     Manolete Partners PLC ("Manolete" or the "Company")   Trading and Business Update Very strong momentum and a return to profit   Manolete...

April 18 2024
RNS Regulatory News

Manolete Partners PLC Appointment of Nominated Adviser and Broker

Manolete Partners PLC 26 February 2024   26 February 2024 MANOLETE PARTNERS PLC ("Manolete", or the "Company") Appointment of Nominated Adviser and Broker   Manolete (AIM:MANO), the leading...

February 26 2024
RNS Regulatory News

Manolete Partners PLC Block Listing Six Monthly Return

Manolete Partners PLC 01 December 2023 1 December 2023 Manolete Partners Plc ("Manolete" or the "Company") Block Listing Six Monthly Return Date: 1 December 2023 Name of...

December 01 2023
UK Regulatory

EARNINGS AND TRADING: Integrated Diagnostics returns to profit

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

November 16 2023
Alliance News

Manolete Partners PLC Half Year Results

Manolete Partners PLC 16 November 2023 16 November 2023 MANOLETE PARTNERS PLC ("Manolete" or the "Company") Half-year results for the six months ended 30 September 2023...

November 16 2023
UK Regulatory

Manolete Partners PLC NOTICE OF HY RESULTS, RETAIL INVESTOR PRESENTATION

Manolete Partners PLC 09 November 2023 9 November 2023 MANOLETE PARTNERS PLC (" Manolete" or the "Company") Notice of Half Year Results and Retail Investor Presentation...

November 09 2023
UK Regulatory

Manolete Partners PLC Presenting at Proactive One2One Investor Forum

Manolete Partners PLC 25 October 2023 25 October 2023 Manolete Partners PLC ("Manolete" or the "Company") Presenting at Proactive One2One Investor Forum Manolete is pleased to...

October 25 2023
RNS Non-Regulatory

Manolete Partners hails boost on removal of UK insolvency protections

Manolete Partners PLC on Wednesday said it is emerging soundly from the UK government's alleged "suppression of the i ...

October 18 2023
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-5-3.38983050847147.5147.514019229143.46216652DE
41511.7647058824127.5147.5122.514595137.99738192DE
12-2.5-1.72413793103145150.5109.519233131.40596688DE
26-5-3.38983050847147.5193109.514933143.04566081DE
52-89.5-38.5775862069232250109.512832166.89061022DE
156-112.5-44.1176470588255330109.523305240.9280789DE
260-375-72.4637681159517.5610109.540539280.52111114DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INHDInno Holdings Inc
$ 0.827
(31.17%)
405.54k
YYAIConnexa Sports Technologies Inc
$ 0.9299
(28.94%)
560
INDPIndaptus Therapeutics Inc
$ 2.50
(18.48%)
48
NIVFNewGenIvf Group Ltd
$ 2.07
(16.29%)
449.46k
FLJFLJ Group Limited
$ 0.635
(15.45%)
126.38k
CLVRClever Leaves Holdings Inc
$ 1.81
(-55.96%)
5.88k
ADXNAddex Therapeutics Ltd
$ 7.94
(-50.68%)
1.34k
ISUNiSun Inc
$ 0.1305
(-22.32%)
84.49k
CYCCCyclacel Pharmaceuticals Inc
$ 1.30
(-13.91%)
2.54k
MNYMoneyHero Ltd
$ 2.00
(-13.79%)
362
PEGYPineapple Energy Inc
$ 0.0713
(13.90%)
1.71M
FFIEFaraday Future Intelligent Electric Inc
$ 0.044
(-6.38%)
840.73k
TSLATesla Inc
$ 178.44
(6.03%)
500.47k
NIVFNewGenIvf Group Ltd
$ 2.07
(16.29%)
449.46k
INHDInno Holdings Inc
$ 0.827
(31.17%)
405.54k

Discussion

View Full Feed
misterfishman misterfishman 3 minutes ago
I was referring to when my sons were new born infants. I didn't like the diaper changes that's for sure but everything else wonderful.
IGPK
jack7377 jack7377 9 minutes ago
NSAV#$$: Hey Bulba, I pity (you) the Fool. You are trying your best to invoke a sell-off . This Puppy is going much Higher and is going to Hold it's gains day after day. Yes"Fool" , see ya at $.015-.02 by Friday's close.
NSAV
Rich4863 Rich4863 20 minutes ago
Youre guilty by association. You should be embarrassed.
AABB
B_B! B_B! 22 minutes ago
The US government is too slow.

Someday soon China might dominate the hydrogen supply chain too
EU and US manufacturers already complaining about Chinese competition in solar power and electric vehicles won’t like China’s hydrogen policy China is already the top producer of hy
PLUG
The Danish Dude The Danish Dude 23 minutes ago
NovoCure management is only in it for one thing only. Pump and dump.

They are once again hoping for being able to pump price up above $20, having recently once again ensured several options to buy more at $16.

I have never seen anyone trading so collectively hard and op
NWBO
diggitydoodle diggitydoodle 23 minutes ago
With nothing going for it, this ticker is proving that it can do everything it's capable of...nothing!
GNCP!???????????????????????????
GNCP
B_B! B_B! 23 minutes ago
“Earnings call will be very interesting and the tax credit news may be significant as well”

I think if both the DOE loan and the positive Q1 results are announced within two weeks, there will be a short squeeze.
PLUG
diggitydoodle diggitydoodle 26 minutes ago
Another new week...
No info, no updates, no fins. Nothing points to anything happening.
Excuses for bad performance have been the norm, instead of positive production.
It just proves no one knows anything about what this ticker is up to. No matter how many old numbers are poste
RNVA
newmedman newmedman 27 minutes ago
[yt]nOsBX7HY2CU[/yt]
Digra Ive Digra Ive 29 minutes ago
Due to FSRN statement.
https://www.caranddriver.com/news/a60233302/fisker-ev-maker-pauses-production/ Production was paused for 6 weeks.
Fisker has announced a six-week pause in production starting the week of March 18, 2024. .
For investors, it means they should return t
FSRN
torontoasian torontoasian 30 minutes ago
This week 🔥 news incoming 🚀💯
SPZI
Sparky1645 Sparky1645 34 minutes ago
Bet it dont happen
SAPX
ShadowDiviner72 ShadowDiviner72 40 minutes ago
So you went bullish now? thought we would never see .15 again?
JAGX
CaptBeer CaptBeer 44 minutes ago
Lately we’ve been getting numerous studies showing that icosapent ethyl is effective and consistent in reducing MACE across a broad range of markers such as TG, LDL-c, Lp(a) and CV Risk Scoring.

This suggests to me that the current labeling for VAZKEPA/VASCEPA is too narrow and becau
AMRN
snow snow 48 minutes ago
irish Yours is one of the most absurd posts I have read for a long time considering the following facts. "By the way, do you contest the facts?)

"Randall Goulding was forbidden by the SEC to have anything to do with any publicly traded company per this ORDER dated 12/20/2022 https://w
SPZI
Single Stock Single Stock 48 minutes ago
NVCR: Novocure to present results of METIS phase 3 trial at ASCO 2024
Novocure announced the results of the METIS phase 3 clinical trial in brain metastases from non-small cell lung cancer will be presented at the 2024 American Society of Clinical Oncology Annual Meeting in Chicago, to be hel
NVCR
B_B! B_B! 48 minutes ago
TotalEnergies chief says oil major will consider moving main listing to New York
Apr 26, 2024 By Steve Goldstein

The chief executive of French oil giant TotalEnergies said it will consider moving its primary stock market listing to New York, where energy rivals command higher
PLUG
Single Stock Single Stock 50 minutes ago
Astra, Daiichi Cancer Medicine Scores Another Trial Win (1)
Medicine slowed disease progression more than chemotherapy
Enhertu is already approved for several types of cancer
By Ashleigh Furlong
(Bloomberg) -- An AstraZeneca Plc and Daiichi Sankyo Co. drug helped slow the
NWBO
adagium adagium 52 minutes ago
It seems like you could use some encouragement/ support while you're searching. In addition to the focus of language interpretations, there are also framing techniques which are sometimes difficult to see through and these influence the 'provision of information' and desperate needs lead to desperat
LWLG
Wise Man Wise Man 57 minutes ago
Now, hit this wall: Definition of Core Capital 12U.S.Code§4502(7)
This is the FHEFSSA, not the U.S. Code:
https://investorshub.advfn.com/uimage/uploads/2023/4/12/mvdguIMG_20210529_080436.jpg

Retained Earnings account is core capital. The only account that absorbs the fut
FNMA
snow snow 57 minutes ago
money-maker The filing by that criminal was made at the end of December 2023!!!!!!!!!!!!!!!!!!!!! It is time posters take this connection between SPZI and a criminal seriously.
SPZI
wickw50 wickw50 60 minutes ago
Q1 results to be reported on May 8th…
AMC
archilles archilles 1 hour ago
Valuator2,
My opinionated analysis is based on all the PR infomation (and/or lack of any opposing information) provided to ENZC shareholders so far and also was based on your post number 197524 in which you suspect that the control of ENZC was relinquished back to Harry under the 4-way agre
ENZC
B_B! B_B! 1 hour ago
Fortescue seeks government help to reduce power prices for stalled 500MW green hydrogen project in Australia
Australian H2 developer has already delayed final investment decision three times on landmark Gibson Island project
Leigh Collins 24 April 2024

The future of For
PLUG

Your Recent History

LSE
MANO
Manolete Partners
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved